Showing 6951-6960 of 9381 results for "".
2017 Tax Cuts and Jobs Act: What You Need to Know
https://practicaldermatology.com/topics/practice-management/2017-tax-cuts-and-jobs-act-what-you-need-to-know--vmyiwowa/18348/OJM Group principal Carole Foos, CPA provides an overview of the Tax Cuts and Jobs Act, which was signed in to law at the end of 2017. She discusses key provisions affecting individual physicians and medical practices, and offers advice to consider when planning for 2018 and beyond. Click here to reUpdates from ASDS 2017
https://practicaldermatology.com/videos/dermwire-tv/updates-from-asds-2017/18411/From microneedling to skin redraping to body contouring, the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) brings cosmetic and surgical dermatology into focus. With an emphasis on the state of the art in dermatologic procedures, the annual meeting of the ASDS gathered hundreItch Be Gone
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/itch-be-gone/18524/Could botulinum toxins be the answer for non-histaminergic itch? Erin Gilbert, MD discusses her research in this area and results she's seen to date.Beyond SPF: Protecting the Skin
https://practicaldermatology.com/topics/skin-cancer-photoprotection/beyond-spf-protecting-the-skin-/18535/In addition to protecting the skin from sun damage, it's becoming increasingly important to consider pollution's role in skin aging. Arianne Shadi Kourosh, MD, and Rebecca Kazin, MD discuss the need for a well tailored regimen and what to look for in sun protection, barrier protection, cleaners, anGalderma's Differin Goes OTC, CoolSculpting Approved for Upper Arms, ZO Skin Acquires ReFissa
https://practicaldermatology.com/videos/dermwire-tv/galderma-s-differin-goes-otc-coolsculpting-approved-for-upper-arms-zo-skin-acquires-refissa/18549/Galderma's Differin Gel formulation of adapalene 0.1% is now available over the counter at major retail and drug stores in the US. ZELTIQ® Aesthetics' CoolSculpting is now FDA-cleared for fat reduction in the upper arms. ZO Skin Health has acquired the worldwide rights to ReFissa from Suneva MedicalEnbrel Gets Nod for Pediatric PsO; IL-33 Targeted in Itch
https://practicaldermatology.com/topics/psoriasis/dermwiretv-enbrel-gets-nod-for-pediatric-pso-il-33-targeted-in-itch/18562/FDA approved Amgen's Enbrel (etanercept) for chronic moderate to severe psoriasis in pediatric patients age 4 to 17. DermCheck App partners with anti-bullying groups Pacer and Not In My Town to help fight bullying and expand acne care. Researchers show that anti-IL-33 antibody reduces itch of poisonAllergan Acquires Vitae, PsA Day, Novan News
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-allergan-acquires-vitae-psa-day-novan-news/18572/Allergan is acquiring clinical-stage biotechnology company Vitae Pharmaceuticals for $21.00 per share, in cash, for a total transaction value of approximately $639 million. Novan has launched its initial public offering and is now listed on the NASDAQ. Celgene Corporation and the National PsoriasisImproving Outcomes with Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/improving-outcomes-with-fillers/18740/For the most optimal outcomes when injecting fillers, Dr. Galadari says there are three essential steps: choose the right patient, choose the right filler, and choose the right injection technique. He shares his favorite types of fillers for specific areas and discusses when and why he uses a cannulGalderma, Allergan Rosacea News, Dupilumab Data
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-galderma-allergan-rosacea-news-dupilumab-data/18591/Galderma Laboratories launched a new pump dispenser design for Mirvaso (brimonidine) Topical Gel, 0.33. The FDA has accepted Allergan's New Drug Application (NDA) filing for oxymetazoline cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema assoTaltz Approved, Venus Versa Cleared, Sunbathing Linked to Longevity
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-taltz-approved-venus-versa-cleared-sunbathing-linked-to-longevity/18788/The IL-17 inhibitor Taltz (ixekizumab) from Eli Lilly is approved for adults with plaque psoriasis. Venus Concepts' Venus Versa is cleared for multiple aesthetic indications. Strata Sciences gets FDA clearance for new "Classifier Code" for use with MelaFind. Vitals.com shows that wait times are goin